Accession Number:

AD1064653

Title:

Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy and Improve Functional Outcomes Following Peripheral Nerve Injury and Repair

Descriptive Note:

Technical Report,30 Sep 2017,29 Sep 2018

Corporate Author:

Johns Hopkins University Baltimore United States

Report Date:

2018-10-01

Pagination or Media Count:

13.0

Abstract:

We have hired and trained all necessary staff. We have received HRPO approval. We obtained IRB approval and continued review approval from JHU IRB and also IRB waivers from our primary recruitment sites Union Memorial Hospital and University of Maryland Medical CenterShockTrauma. The placebo purchase agreement and material transfer agreement have been agreed on and signed by JHU and Thera technologies responsible officials. We have enrolled and screened our first patient to the trial.

Subject Categories:

  • Anatomy and Physiology
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE